Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Lumos Pharma: Q1 Earnings Insights

Lumos Pharma (NASDAQ:LUMO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lumos Pharma missed estimated earnings by 3.37%, reporting an EPS of $-0.92 versus an estimate of $-0.89.
byBenzinga Insights
May 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Lumos Pharma (NASDAQ:LUMO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Lumos Pharma missed estimated earnings by 3.37%, reporting an EPS of $-0.92 versus an estimate of $-0.89.

Revenue was up $111.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.24 which was followed by a 6.82% drop in the share price the next day.

To track all earnings releases for Lumos Pharma visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

4 Affirm Holdings Analysts Offer Takes On Downbeat Quarter: Company Having ‘Economic And Credit Cycle Turbulence’

By Priya Nigam
Today, 2:44 AM
Affirm Holdings Inc (NASDAQ: AFRM) reported $364.1 million in sales for its fiscal fourth quarter, missing the consensus estimate of $365 million in sales, and a loss of 65 cents per share, significantly worse than Street expectations of a loss of 58 cents per share.

AFRM